CompletedPHASE1, PHASE2NCT01263379

Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa

Studying Dystrophic epidermolysis bullosa

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Abeona Therapeutics, Inc
Principal Investigator
Jean Tang, MD, PhD
Stanford University
Intervention
LZRSE-Col7A1 Engineered Autologous Epidermal Sheets(biological)
Enrollment
12 enrolled
Eligibility
13 years · All sexes
Timeline
2010 – 2022

Study locations (1)

Collaborators

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · Stanford University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01263379 on ClinicalTrials.gov

Other trials for Dystrophic epidermolysis bullosa

Additional recruiting or active studies for the same condition.

See all trials for Dystrophic epidermolysis bullosa →

← Back to all trials